Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 16Unknown 8Terminated 6Recruiting 3Withdrawn 2Not yet recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Sarcoma 8Stomach Neoplasms 7Esophageal Neoplasms 7Breast Neoplasms 7Neoplasms 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Carcinoma, Hepatocellular 5Recurrence 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Neoplasm Metastasis 4Thyroid Neoplasms 3Nasopharyngeal Carcinoma 3Melanoma 3Laryngeal Neoplasms 3Head and Neck Neoplasms 3Glioma 3Glioblastoma 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Osteosarcoma 2Mouth Neoplasms 2Hyperthermia 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2

Interventions

Bevacizumab 77Fluorouracil 55Cetuximab 48Oxaliplatin 43Leucovorin 42pembrolizumab 37Irinotecan 33Folfox protocol 24Capecitabine 24HMPL-013 22Specimen Handling 19trifluridine tipiracil drug combination 17Panitumumab 15Blood Specimen Collection 15Nivolumab 14Magnetic Resonance Spectroscopy 14regorafenib 13Biopsy 13Trifluridine 12Gemcitabine 12Cisplatin 12Standard of Care 11sintilimab 10Interviews as Topic 10IFL protocol 10Drug Therapy 10Carboplatin 10Cyclophosphamide 9tislelizumab 8Trastuzumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Colorectal Neoplasms × Surgical Procedures, Operative × Clear all
NCT06307548 2026-05-06

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Roswell Park Cancer Institute

Phase 1/2 Recruiting
21 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06850103 2026-03-25

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

First Affiliated Hospital of Zhejiang University

Phase 2 Recruiting
51 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06269978 2026-03-10

Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer

Ohio State University Comprehensive Cancer Center

Phase 1 Recruiting
24 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡